198HO02140 CROMO *PP

Print/PDF
Registration Name LA BAGOLINA IRONGEN CROMO
Registration Number HOITA024990603026
Primary NAAB Code 198HO02140
Secondary Code(s)
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 7/30/2017
aAa 234165
DMS -
GFI 9.4%
Genetic Codes * TC TL PP TY TV TD TR TM TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-A
Sire ANDERSTRUP CLASH
MGS HUBERTUS ORACLE-ET
Beta Casein A2A2
Kappa Casein AB
Beta Lactoglobulin AB
INDEXES
NM$ -155, 82% R CM$ -144
NM Percentile 13% FM$ -186
GTPI 2236 GM$ -125
PRODUCTION TRAITS
1382 Dtrs 485 herds 0 % US 90% R
Milk 23 Fat, % -35 , -0.14%
SCS 3.22, 90% R Protein, % 12 , +0.04%
Feed Saved 255 , 52% R Milking Speed 6.97 , 62% R
Health & Fertility
Productive Life -1.8      90% R Mastitis -1.9      72% R
Heifer Livability 0.2       51% R Metritis -0.6      68% R
Livability -0.8      81% R D. Abom -0.5      71% R
DPR -0.4      89% R Ketosis -0.4      68% R
HCR -0.9      85% R R. Placenta -0.4      69% R
FSC -1.7      74% R Milk Fever -0.1      61% R
CCR -0.7      88% R
SCR -        -
DIA 0.3      39% R
RSP 0.3      45% R
Calving Traits
Sire CE 1.0      58% R 2555 Obs
Daughter CE 1.7      42% R 0 Obs, 1985 Dtrs
Sire SB 3.9      43% R 3272 Obs
Daughter SB 3.9      59% R 0 Obs, Dtrs
Gestation Length 0.3      76% R 0 Obs, 0 Dtrs
Early First Calving -1.6      73% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
378 Dtrs 201 herds 88% R
PTA Type -0.69 UDC -0.89
HCC -2.04 BWC -1.23
FLC -0.92
Linear Traits
Stature 0.67
Tall
Strength -1.34
Strong
Body Depth -0.68
Shallow
Dairy Form 0.86
Open
Rump Angle 2.24
Sloped
Thurl Width 0.22
Wide
Rear Legs-Side View 1.38
Curved
Rear Legs-Rear View -0.94
H.-in
Foot Angle -2.01
Low
Feet & Legs Score -0.49
Low
F.U. Attachment -1.31
Weak
Rear Udder Height -0.70
Low
Rear Udder Width -0.70
Narrow
Udder Cleft -0.78
Weak
Udder Depth 0.02
Shallow
Front Teat Placement 0.11
Close
Rear Teat Placement -0.31
Wide
Teat Length -1.12
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO